Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun;10(Suppl 17):S1966-S1970.
doi: 10.21037/jtd.2018.04.106.

Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment

Malgorzata Szolkowska  1 , Katarzyna Blasinska-Przerwa  2 , Magdalena Knetki-Wroblewska  3 , Piotr Rudzinski  4 , Renata Langfort  1
Affiliations
Editorial

Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment

Malgorzata Szolkowska et al. J Thorac Dis. 2018 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: M Szolkowska discloses paid lectures for MSD Polska, Roche Polska and AstraZeneca Pharma Poland and an involvement in a clinical trial sponsored by Roche. M Knetki-Wroblewska discloses paid lectures for Bristol-Myers Squibb and an involvement in clinical trials sponsored by Boehringer Ingelheim and Bristol-Myers Squibb. P Rudzinski discloses an involvement in a clinical trial sponsored by Roche. R Langfort discloses paid lectures for MSD Polska, Roche Polska, AstraZeneca Pharma Poland, Bristol-Myers Squibb, Pfizer Polska, Boehringer Ingelheim and Eli Lilly Polska and an involvement in a clinical trial sponsored by Roche. K Blasinska-Przerwa has no conflicts of interest to declare.

Comment on

References

    1. Metintaş S, Batırel HF, Bayram H, et al. Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. Int J Environ Res Public Health 2017;14. - PMC - PubMed
    1. Carder M, Darnton A, Gittins M, et al. Chest physician-reported, work-related, long-latency respiratory disease in Great Britain. Eur Respir J 2017;50. - PubMed
    1. Baas P, Fennell D, Kerr KM, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26:v31-9. 10.1093/annonc/mdv199 - DOI - PubMed
    1. Kindler HL, Ismaila N, Armato SG, 3rd, et al. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2018;36:1343-73. 10.1200/JCO.2017.76.6394 - DOI - PMC - PubMed
    1. Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group Arch Pathol Lab Med 2018;142:89-108. 10.5858/arpa.2017-0124-RA - DOI - PubMed

LinkOut - more resources